Work

Once-weekly rifapentine and isoniazid for tuberculosis prevention in patients with HIV taking dolutegravir-based antiretroviral therapy: a phase 1/2 trial

Year: 2020

Type: article

Study design: Clinical Trial

Source: The Lancet HIV

DOI: 10.1016/s2352-3018(20)30032-1

Authors: Kelly E Dooley, Radojkam Savic, Akshay Gupte, Mark A Marzinke, Nan Zhang, Vinodh A Edward, Lisa Wolf, Modulakgotla Sebe, Morongwe Likoti, Mark J Fyvie, Innocent Shibambo, Trevor Beattie, Richard E Chaisson, Gavin J Churchyard

Institutions: Johns Hopkins University, Johns Hopkins Medicine, University of California, San Francisco, University of the Witwatersrand, Yale University, Aurum Institute

Language: English

Topic: Tuberculosis Research and Epidemiology

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3014021031

FWCI: 1.278

Cites: 22

Cited by: 65

Related to: 10